Pharma-Bio Serv, Inc. (PBSV) Financial Statements (2024 and earlier)

Company Profile

Business Address INDUSTRIAL ZONE STREET 1
DORADO, 00646
State of Incorp.
Fiscal Year End October 31
Industry (SIC) 8742 - Management Consulting Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

7/31/2023
MRQ
1/31/2023
MRQ
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,24714,46317,46817,13815,49016,074
Cash and cash equivalents 14,46317,46817,13815,49016,030
Short-term investments8,247    44
Receivables4,3264,9834,61310,97810,0316,943
Other current assets    469454394
Other undisclosed current assets7,663498741   
Total current assets:20,23619,94422,82228,58425,97523,412
Noncurrent Assets
Operating lease, right-of-use asset467503640847 
Property, plant and equipment6674106218291298
Long-term investments and receivables      1,250
Accounts and financing receivable, after allowance for credit loss      1,250
Other noncurrent assets  131353270367418
Other undisclosed noncurrent assets131     
Total noncurrent assets:6647071,0991,3356581,967
TOTAL ASSETS:20,90020,65123,92129,91926,63325,378
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,8181,6302,0711,9381,5902,140
Interest and dividends payable  1,725 
Taxes payable1,851392344412
Accounts payable 1,329     
Accrued liabilities489337    
Other undisclosed accounts payable and accrued liabilities 1,2922211,546(479)1,728
Debt    1,2991114
Other undisclosed current liabilities1444785805552,069412
Total current liabilities:1,9612,1082,6513,7933,6712,566
Noncurrent Liabilities
Long-term debt and lease obligation   4876856746
Capital lease obligations6746
Finance lease, liability    55 
Liabilities, other than long-term debt310347 2,0622,2882,503
Accounts payable and accrued liabilities   2,0622,2702,485
Other liabilities     1818
Operating lease, liability310347487630 
Other undisclosed noncurrent liabilities 1,6391,6391,381662  
Total noncurrent liabilities:1,9491,9862,3563,4092,3552,549
Total liabilities:3,9104,0935,0077,2026,0265,115
Equity
Equity, attributable to parent16,99016,55818,91422,71720,60820,264
Common stock222222
Treasury stock, value(502)(502)(420)(394)(393)(305)
Additional paid in capital1,5671,5521,4801,4241,3811,347
Accumulated other comprehensive income230238144161144108
Retained earnings15,69415,26717,70721,52419,47319,111
Other undisclosed equity 2,000     
Total equity:18,99016,55818,91422,71720,60820,264
TOTAL LIABILITIES AND EQUITY:22,90020,65123,92129,91926,63325,378

Income Statement (P&L) ($ in thousands)

7/31/2023
TTM
1/31/2023
TTM
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
Revenues18,61819,39920,11521,56419,50717,797
Cost of revenue(13,741)(14,517)(14,755)(14,898)(13,330)(12,111)
Gross profit:4,8774,8815,3606,6676,1775,687
Operating expenses(3,729)(3,707)(9,214)(4,441)(4,433)(4,593)
Other undisclosed operating income (loss)     343(2,356)
Operating income (loss):1,1481,175(3,854)2,2262,087(1,262)
Nonoperating income259131,97864527436
Other nonoperating income259131,978   
Income (loss) from continuing operations before equity method investments, income taxes:1,4071,188(1,876)2,2902,614(826)
Other undisclosed income (loss) from continuing operations before income taxes     (391)2,350
Income (loss) from continuing operations before income taxes:1,4071,188(1,876)2,2902,2231,524
Income tax expense(279)(182)(213)(239)(136)(2,786)
Income (loss) from continuing operations:1,1281,007(2,089)2,0512,087(1,262)
Income (loss) before gain (loss) on sale of properties:528(2,089)2,0512,0871,280
Income from discontinued operations      2,541
Other undisclosed net loss      
Net income (loss):1,1281,007(2,089)2,0512,0871,280
Other undisclosed net income attributable to parent      
Net income (loss) available to common stockholders, diluted:1,1281,007(2,089)2,0512,0871,280

Comprehensive Income ($ in thousands)

7/31/2023
TTM
1/31/2023
TTM
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
Net income (loss):1,1281,007(2,089)2,0512,0871,280
Other comprehensive loss      
Comprehensive income (loss):1,1281,007(2,089)2,0512,0871,280
Other undisclosed comprehensive income (loss), net of tax, attributable to parent11194(16)1736(30)
Comprehensive income (loss), net of tax, attributable to parent:1,2391,100(2,105)2,0682,1231,250

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: